FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2588631454> ?p ?o ?g. }

• W2588631454 endingPage "vi291" @default.
• W2588631454 startingPage "vi291" @default.
• W2588631454 abstract "Treatment of metastatic germ cell cancer (GCC) is based on the International Germ Cell Cancer Collaborative Group (IGCCCG) prognostic classification published in 1997. 5-year survival rates were reported to be 91%, 79%, and 48% for patients with good, intermediate and poor prognosis, respectively. The question arises whether treatment results improved over time due to cumulative experience and whether there is still a need for dose intensification in intermediate and poor risk patients. The records of all patients (pts) with metastatic GCC treated at two institutions in Munich between 2000 and 2013 were reviewed with regard to time of initial diagnosis, histopathology, stage, tumor marker levels, metastatic spread, type and duration of chemotherapy (CT), and outcome. Progression-free survival (PFS) and overall survival (OS) were estimated with the Kaplan-Meyer method. The Log-rank test was used to compare survival distributions of different groups. Of 255 patients identified, 30 pts were excluded due to incomplete data. 189 of 225 pts (84%) included into the study were treated as outpatients and 36 (16%) as inpatients. The median age was 35 years, seminoma and nonseminoma were diagnosed in 72 (32%) and 153 (68%) pts, and 204 pts (91%) had a primary gonadal GCC. 175 (78%), 30 (13%) and 20 pts (9%) had good, intermediate and poor prognosis according to the IGCCCG classification system. The vast majority of pts received 3 to 4 cycles of platinum-based CT while primary high-dose CT was applied to 3 pts in the poor prognosis group. The 2-year-PFS of pts with good, intermediate and poor prognosis was 91%, 83% and 37%, and the 5-year-OS was 98%, 96%, and 66%, respectively. There was no significant difference in the 5-year-OS between pts in the good and intermediate prognosis group. Compared to data from the 1997 IGCCCG classification system, the outcome of pts with metastastic GCC has considerably improved. Notably, no significant differences in the 5-year-OS were observed between pts with good and intermediate prognosis. While the outcome of pts with intermediate-prognosis is excellent, treatment results in the poor-prognosis group are still unsatisfactory." @default.
• W2588631454 created "2017-02-24" @default.
• W2588631454 creator A5030071814 @default.
• W2588631454 creator A5064876385 @default.
• W2588631454 creator A5087044377 @default.
• W2588631454 date "2016-10-01" @default.
• W2588631454 modified "2023-09-27" @default.
• W2588631454 title "Outcome of patients with metastatic germ cell cancer treated between 2000 and 2013 at two centers in Munich" @default.
• W2588631454 doi "https://doi.org/10.1093/annonc/mdw373.63" @default.
• W2588631454 hasPublicationYear "2016" @default.
• W2588631454 type Work @default.
• W2588631454 sameAs 2588631454 @default.
• W2588631454 citedByCount "0" @default.
• W2588631454 crossrefType "journal-article" @default.
• W2588631454 hasAuthorship W2588631454A5030071814 @default.
• W2588631454 hasAuthorship W2588631454A5064876385 @default.
• W2588631454 hasAuthorship W2588631454A5087044377 @default.
• W2588631454 hasBestOaLocation W25886314541 @default.
• W2588631454 hasConcept C10515644 @default.
• W2588631454 hasConcept C121608353 @default.
• W2588631454 hasConcept C126322002 @default.
• W2588631454 hasConcept C141071460 @default.
• W2588631454 hasConcept C142724271 @default.
• W2588631454 hasConcept C143998085 @default.
• W2588631454 hasConcept C146357865 @default.
• W2588631454 hasConcept C151730666 @default.
• W2588631454 hasConcept C2776694085 @default.
• W2588631454 hasConcept C2776938808 @default.
• W2588631454 hasConcept C2778074268 @default.
• W2588631454 hasConcept C544855455 @default.
• W2588631454 hasConcept C66339696 @default.
• W2588631454 hasConcept C71924100 @default.
• W2588631454 hasConcept C86803240 @default.
• W2588631454 hasConceptScore W2588631454C10515644 @default.
• W2588631454 hasConceptScore W2588631454C121608353 @default.
• W2588631454 hasConceptScore W2588631454C126322002 @default.
• W2588631454 hasConceptScore W2588631454C141071460 @default.
• W2588631454 hasConceptScore W2588631454C142724271 @default.
• W2588631454 hasConceptScore W2588631454C143998085 @default.
• W2588631454 hasConceptScore W2588631454C146357865 @default.
• W2588631454 hasConceptScore W2588631454C151730666 @default.
• W2588631454 hasConceptScore W2588631454C2776694085 @default.
• W2588631454 hasConceptScore W2588631454C2776938808 @default.
• W2588631454 hasConceptScore W2588631454C2778074268 @default.
• W2588631454 hasConceptScore W2588631454C544855455 @default.
• W2588631454 hasConceptScore W2588631454C66339696 @default.
• W2588631454 hasConceptScore W2588631454C71924100 @default.
• W2588631454 hasConceptScore W2588631454C86803240 @default.
• W2588631454 hasLocation W25886314541 @default.
• W2588631454 hasOpenAccess W2588631454 @default.
• W2588631454 hasPrimaryLocation W25886314541 @default.
• W2588631454 hasRelatedWork W167319750 @default.
• W2588631454 hasRelatedWork W1987468340 @default.
• W2588631454 hasRelatedWork W2024911504 @default.
• W2588631454 hasRelatedWork W2145575862 @default.
• W2588631454 hasRelatedWork W2170553016 @default.
• W2588631454 hasRelatedWork W2383214251 @default.
• W2588631454 hasRelatedWork W2389122334 @default.
• W2588631454 hasRelatedWork W2466839670 @default.
• W2588631454 hasRelatedWork W2469952935 @default.
• W2588631454 hasRelatedWork W3030381566 @default.
• W2588631454 hasVolume "27" @default.
• W2588631454 isParatext "false" @default.
• W2588631454 isRetracted "false" @default.
• W2588631454 magId "2588631454" @default.
• W2588631454 workType "article" @default.